Search

everythinglearnresearchcommunity

for

Search:↓

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Some drugs may help treat both COVID-19 and radiation injury.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

iPSCs are promising for studying and treating COVID-19.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

COVID-19 may trigger sudden temporary hair loss.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Natural products may be safer and effective alternatives for managing heart attacks.

Cannabis has anti-inflammatory and antimicrobial properties, but more research is needed on its effects on plant and aquatic animal pathogens.

We need safe, affordable drugs to fight coronaviruses effectively.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

South African wild foods may help prevent cardiovascular disease.

Researchers converted human embryonic stem cells into trophoblast stem cells using specific transcription factors.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Gender and social factors, not just biology, affect COVID-19 death rates.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.